3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
1
Interventions
Specimen Handling
80
Fluorouracil
75
Oxaliplatin
67
Magnetic Resonance Spectroscopy
61
Leucovorin
59
Bevacizumab
56
Gemcitabine
53
Biopsy
41
Irinotecan
37
Capecitabine
37
pembrolizumab
35
Cisplatin
35
Nivolumab
33
Cetuximab
32
130-nm albumin-bound paclitaxel
28
Paclitaxel
27
durvalumab
26
atezolizumab
21
Folfox protocol
20
Radiotherapy
17
Carboplatin
17
Taxes
16
dehydroftorafur
15
Radiation
14
Cyclophosphamide
14
X-Rays
13
Albumin-Bound Paclitaxel
13
trastuzumab deruxtecan
12
fludarabine
12
Surgical Procedures, Operative
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chemoradiotherapy, Adjuvant
×
Gastrointestinal
×
30 days
×
Clear all
NCT05667298
2026-05-11
OPERARADIO
University of Manitoba
Phase 1
Active not recruiting
11 enrolled